DARU Journal of Pharmaceutical Sciences will cease to be published by BioMed Central from 31 Dec 2017. BioMed Central will continue to host an archive of all articles previously published in the journal and all articles published in DARU Journal of Pharmaceutical Sciences during its time with BioMed Central will remain fully searchable via the BioMed Central website.
Aims and scope
DARU Journal of Pharmaceutical Sciences is an open access, peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment. The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.
DARU Journal of Pharmaceutical Sciences is supported by Tehran University of Medical Sciences. The article-processing charge (APC) that is payable upon editorial acceptance of an article is €850. Further details on the APC are available here.
Note for Iran-based authors
For authors based in Iran a discounted APC of €700 and a special mechanism for covering the APC apply. Iran-based authors should enter the code DARU01 during the article submission process. If this code is used, Iran-based authors do not pay an APC to the publisher; instead, TUMS arranges payments with the publisher and will invoice the APC, payable in Iranian Rials, to the authors.
Previous issues of DARU Journal of Pharmaceutical Sciences, published by Tehran University of Medical Sciences, can be found here. This includes all content from 1990-2011.
CWTS Journal Indicator for DARU
Click here to see the CWTS Journal Indicator for DARU Journal of Pharmaceutical Sciences.
Mohammad Abdollahi (MA) acquired a PharmD in 1988 from the University of Tehran and then finished a PhD in Toxicology and Pharmacology in 1994 from the Tehran University of Medical Sciences. He gained postdoctoral training at the University of Toronto in 2001 in the fields of Mechanistic and Clinical Toxicopharmacology. MA has obtained the honor of full professorship of Tehran University of Medical Sciences since 2002. MA has been Dean of Department (Toxicology & Pharmacology) since 2005. MA has been one of the main Founders of the Pharmaceutical Sciences Research Centers of TUMS since 2002. Also MA has been the Secretary of National Board of Toxicology for 9 years and Chair of National Society of Toxicology for 8 years. MA is the Secretary of the Council for Pharmaceutical Education in Iranian Ministry of Health & Medical Education and Chair of the Drug Discovery and Evaluation Department in National Institute of Medical Research Development. So far, MA has contributed in authoring more than 700 papers in prestigious journals and authoring 50 book chapters and editing 12 books. MA has been listed among top scientists of ESI/ISI and OIC Member States. According to GS, current H-index, total citations, and i10 index of MA are 68, >18000, and 370, respectively. Besides having the position of DARU Editor-in-Chief (EiC), MA is in the editorial board of many journals and EiC of the Journal of Medical Hypotheses and Ideas. MA has cooperated with some key international organizations such as OPCW (Organization for Prohibition of Chemical Weapons) as a Scientific Advisory Board in the Netherlands, WHO (World Health Organization) as a Member of Guideline Developing Group for Prevention of Lead Poisoning in Switzerland, COPE (Committee on Publication Ethics) as Council Member in the UK, and IAS (Islamic-World Academy of Sciences) as a Fellow. In addition to more than ten prestigious national awards, MA has received the prominent award of IAS-COMSTECH in 2005 in the field of Pharmacology & Toxicology. The main research interests of MA are Mechanistic and Environmental Toxicology, Evidence-Based Medicine, and Pharmacology.